Anti-inflammatory, Anti-fibrotic and Pro-cardiomyogenic Effects of Genetically Engineered Extracellular Vesicles Enriched in miR-1 and miR-199a on Human Cardiac Fibroblasts.
Katarzyna Kmiotek-WasylewskaSylwia Bobis-WozowiczElżbieta KarnasMonika OrpelOlga WoźnickaZbigniew MadejaBuddhadeb DawnEwa K Zuba-SurmaPublished in: Stem cell reviews and reports (2023)
hiPS-EVs carrying miR-1 and miR-199a attenuate apoptosis and pro-fibrotic and pro-inflammatory activities of CFs, and increase cardiomyogenic gene expression. These finding serve as rationale for targeting fibroblasts with novel EV-based miRNA therapies to improve heart repair after myocardial injury.